The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Data Process Mapping Tools and Strategies in Data Integrity Governance (Sept 5, 2025)" training has been added to ResearchAndMarkets.com's offering. This ...
Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...
The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...
Dublin, Feb. 17, 2020 (GLOBE NEWSWIRE) -- The "Data Integrity: FDA/EU Requirements and Implementation" conference has been added to ResearchAndMarkets.com's offering. This 2-day course explains the ...
Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...
Protecting bioanalytical data integrity from bench to report - A Thermo Fisher Scientific White Paper ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Real-World Quality Management Systems and Data Integrity Compliance Tactics (July 30, 2025)" training has been added to ResearchAndMarkets.com's offering ...
A quiet revolution is reshaping America’s pharmaceutical manufacturing capabilities—one that blends cutting-edge science, ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--DvSum, a leader in data intelligence management, is pleased to announce its partnership with Booz Allen Hamilton and the U.S. Food and Drug Administration (FDA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results